Premorbid body mass index and risk of amyotrophic lateral sclerosis
- PMID: 23134505
- PMCID: PMC3615420
- DOI: 10.3109/21678421.2012.735240
Premorbid body mass index and risk of amyotrophic lateral sclerosis
Abstract
Our objective was to determine if amyotrophic lateral sclerosis (ALS) risk varies according to body mass index (BMI) captured up to three decades earlier. At baseline 537,968 females and 562,942 males in five ongoing cohorts reported height, current weight and weight at age 18/21 years. During 14-28 years of follow-up, 1153 participants developed ALS. Cohort-specific Cox proportional hazards models were used to estimate rates that were then pooled with random-effects models. Results showed that lower BMI at baseline was associated with ALS; for each 5-unit increase in BMI, ALS rates were 21% lower (95% CI 14% 27%). Compared to individuals with healthy BMI, ALS rates were significantly lower among the overweight (RR = 0.76 (95% CI 0.62-0.93)) and obese (RR = 0.73 (95% CI 0.55-0.96)). Among never smokers the association persisted: RR = 0.75 (95% CI 0.65-0.85) for each 5-unit increase. Excluding the first seven years of follow-up, the associations were materially unchanged suggesting that weight loss from undiagnosed disease does not fully explain the findings. Overall, 75% of males and females had a healthy BMI at age 18/21 years, 15% of males and 8% of females were overweight or obese; there was no association with ALS although numbers with an unhealthy weight were small. In conclusion, these findings support an association between lower premorbid BMI and ALS.
Figures

Similar articles
-
Prediagnostic body size and risk of amyotrophic lateral sclerosis death in 10 studies.Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):396-406. doi: 10.1080/21678421.2018.1452944. Epub 2018 Apr 16. Amyotroph Lateral Scler Frontotemporal Degener. 2018. PMID: 29658324 Free PMC article.
-
Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia.Eur J Epidemiol. 2017 Oct;32(10):901-908. doi: 10.1007/s10654-017-0318-z. Epub 2017 Oct 3. Eur J Epidemiol. 2017. PMID: 28975435
-
High BMI is associated with low ALS risk: A population-based study.Neurology. 2019 Jul 30;93(5):e424-e432. doi: 10.1212/WNL.0000000000007861. Epub 2019 Jun 26. Neurology. 2019. PMID: 31243073
-
Systematic review of the prognostic role of body mass index in amyotrophic lateral sclerosis.Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):356-367. doi: 10.1080/21678421.2019.1587631. Epub 2019 Apr 1. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 30931632
-
Body mass index and survival from amyotrophic lateral sclerosis: A meta-analysis.Neurol Clin Pract. 2018 Oct;8(5):437-444. doi: 10.1212/CPJ.0000000000000521. Neurol Clin Pract. 2018. PMID: 30564498 Free PMC article. Review.
Cited by
-
High-fat and ketogenic diets in amyotrophic lateral sclerosis.J Child Neurol. 2013 Aug;28(8):989-92. doi: 10.1177/0883073813488669. Epub 2013 May 10. J Child Neurol. 2013. PMID: 23666040 Free PMC article.
-
From animal models to human disease: a genetic approach for personalized medicine in ALS.Acta Neuropathol Commun. 2016 Jul 11;4(1):70. doi: 10.1186/s40478-016-0340-5. Acta Neuropathol Commun. 2016. PMID: 27400686 Free PMC article. Review.
-
Androgen Therapy in Neurodegenerative Diseases.J Endocr Soc. 2020 Aug 21;4(11):bvaa120. doi: 10.1210/jendso/bvaa120. eCollection 2020 Nov 1. J Endocr Soc. 2020. PMID: 33094209 Free PMC article. Review.
-
Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis.Neurotherapeutics. 2022 Jul;19(4):1102-1118. doi: 10.1007/s13311-022-01262-3. Epub 2022 Jun 30. Neurotherapeutics. 2022. PMID: 35773551 Free PMC article. Review.
-
Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis.Nutrients. 2021 Oct 26;13(11):3804. doi: 10.3390/nu13113804. Nutrients. 2021. PMID: 34836059 Free PMC article. Review.
References
-
- Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002;59(5):773–5. - PubMed
-
- Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr. 1996;63(1):130–7. - PubMed
-
- Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74(3):328–34. - PubMed
-
- Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. Journal of neurology. 2009;256(8):1236–42. Epub 2009/03/24. - PubMed
-
- Funalot B, Desport JC, Sturtz F, Camu W, Couratier P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10(2):113–7. Epub 2008/09/17. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous